These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10491736)

  • 1. Biochemical markers of bone turnover.
    Hart SM; Eastell R
    Curr Opin Nephrol Hypertens; 1999 Jul; 8(4):421-7. PubMed ID: 10491736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical markers of bone turnover in Paget's disease of bone.
    Eastell R
    Bone; 1999 May; 24(5 Suppl):49S-50S. PubMed ID: 10321928
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity.
    Alvarez L; Peris P; Pons F; Guañabens N; Herranz R; Monegal A; Bedini JL; Deulofeu R; Martínez de Osaba MJ; Muñoz-Gómez J; Ballesta AM
    Arthritis Rheum; 1997 Mar; 40(3):461-8. PubMed ID: 9082934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmatic markers of bone metabolism.
    Tamburino G; Fiore CE
    Ann Ital Med Int; 1990; 5(3 Pt 3):296-302. PubMed ID: 2081090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone.
    Delmas PD; Demiaux B; Malaval L; Chapuy MC; Meunier PJ
    Calcif Tissue Int; 1986 Jan; 38(1):60-1. PubMed ID: 3079654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical use of the new biochemical markers of bone metabolism].
    Rodríguez Espinosa J; Queraltó Compañó JM
    Med Clin (Barc); 1998 Sep; 111(7):259-62. PubMed ID: 9789241
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.
    Hosking D; Lyles K; Brown JP; Fraser WD; Miller P; Curiel MD; Devogelaer JP; Hooper M; Su G; Zelenakas K; Pak J; Fashola T; Saidi Y; Eriksen EF; Reid IR
    J Bone Miner Res; 2007 Jan; 22(1):142-8. PubMed ID: 17032148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry.
    Glendenning P; Kent GN; Adler BD; Matz L; Watson I; O'Driscoll GJ; Hurley DM
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):347-55. PubMed ID: 10435061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.
    Shai F; Baker RK; Wallach S
    J Clin Invest; 1971 Sep; 50(9):1927-40. PubMed ID: 4935444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling].
    Garnero P; Bianchi F; Carlier MC; Genty V; Jacob N; Kamel S; Kindermans C; Plouvier E; Pressac M; Souberbielle JC
    Ann Biol Clin (Paris); 2000; 58(6):683-704. PubMed ID: 11098165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis.
    Torres R; de la Piedra C; Rapado A
    Scand J Clin Lab Invest; 1989 May; 49(3):279-85. PubMed ID: 2787049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity.
    Pons F; Alvarez L; Peris P; Guañabens N; Vidal-Sicart S; Monegal A; Pavía J; Ballesta AM; Muños-Gómez J; Herranz R
    Nucl Med Commun; 1999 Jun; 20(6):525-8. PubMed ID: 10451864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone turnover markers in Paget's disease of the bone: A Systematic review and meta-analysis.
    Al Nofal AA; Altayar O; BenKhadra K; Qasim Agha OQ; Asi N; Nabhan M; Prokop LJ; Tebben P; Murad MH
    Osteoporos Int; 2015 Jul; 26(7):1875-91. PubMed ID: 26037791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary gamma-carboxyglutamic acid and serum osteocalcin as bone markers: studies in osteoporosis and Paget's disease.
    Gundberg CM; Lian JB; Gallop PM; Steinberg JJ
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1221-5. PubMed ID: 6605357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's Disease.
    Lauffenburger T; Olah AJ; Dambacher MA; Guncaga J; Lentner C; Haas HG
    Metabolism; 1977 Jun; 26(6):589-606. PubMed ID: 404501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of bone turnover for the clinical investigation of osteoporosis.
    Delmas PD
    Osteoporos Int; 1993; 3 Suppl 1():81-6. PubMed ID: 8461587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disorder of bone quality in Paget's disease].
    Tsurukami H
    Clin Calcium; 2005 Jun; 15(6):1000-6. PubMed ID: 15930714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term skeletal retention and recirculation of 85Sr in man.
    Smith DA; Speirs CF; Shimmins J
    Calcif Tissue Res; 1967; 1(2):144-52. PubMed ID: 6060151
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of therapeutic intervention on bone mass and turnover through monitoring of biochemical markers of bone turnover].
    Ohta H
    Nihon Rinsho; 2006 Sep; 64(9):1663-9. PubMed ID: 16972676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical assessment of Paget's disease of bone.
    Shankar S; Hosking DJ
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P22-7. PubMed ID: 17229003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.